“…Unlike conventional antibiotics that kill bacterial cells or inhibit their growth, capsule depolymerases degrade bacterial surface polysaccharides to reduce their virulence and expose bacteria to host immune attack (Majkowska-Skrobek et al, 2016Liu et al, 2019a,b;Oliveira et al, 2019). The potential of phage-encoded depolymerases of targeting various K. pneumoniae capsules have been demonstrated previously (Hsu et al, 2013;Lin et al, 2014;Pan et al, 2015Pan et al, , 2017Pan et al, , 2019Majkowska-Skrobek et al, 2016Hsieh et al, 2017;Cai et al, 2019;Wu et al, 2019). Recently, the depolymerase Dep42 encoded by phage SH-KP152226 could specifically degrade the K47 capsule of K. pneumoniae and was able to significantly inhibit biofilm formation or degrade formed biofilms (Wu et al, 2019).…”